XAIR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XAIR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-28), Beyond Air's share price is $1.165. Beyond Air's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.55. Hence, Beyond Air's Price to Tangible Book Ratio of today is 2.14.
The historical rank and industry rank for Beyond Air's Price-to-Tangible-Book or its related term are showing as below:
During the past 9 years, Beyond Air's highest Price to Tangible Book Ratio was 215.83. The lowest was 2.12. And the median was 5.72.
A closely related ratio is called PB Ratio. As of today, Beyond Air's share price is $1.165. Beyond Air's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.59. Hence, Beyond Air's P/B Ratio of today is 1.98.
The historical data trend for Beyond Air's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air Annual Data | |||||||||||||||||||
Trend | Jun15 | Jun16 | Dec17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | ||||||||||
Price-to-Tangible-Book | Get a 7-Day Free Trial | 11.85 | 7.27 | 3.99 | 2.82 | 5.72 |
Beyond Air Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Price-to-Tangible-Book | Get a 7-Day Free Trial | 3.95 | 5.72 | 3.99 | 3.05 | 3.60 |
For the Medical Devices subindustry, Beyond Air's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Beyond Air's Price-to-Tangible-Book falls into.
Beyond Air's price-to-tangible-book ratio for today is calculated as:
Price to Tangible Book | = | Share Price | / | Tangible Book per Share (Q: Dec. 2023 ) |
= | 1.165 | / | 0.545 | |
= | 2.14 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price to Tangible Book | = | Market Cap | / | Tangible Equity | ||||
= | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock | - | Intangible Assets) |
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Beyond Air's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Amir Avniel | director, officer: President & CEO | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
Jeff Lynn Myers | officer: Chief Medical Officer | C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY NY 11530 |
Robert Carey | director | HORIZON PHARMA, INC., 520 LAKE COOK ROAD, SUITE 520, DEERFIELD IL 60062 |
Steven A. Lisi | director | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
Michael A. Gaul | officer: Chief Operating Officer | 425 MARTINGALE ROAD, SUITE 1000, SCHAUMBURG IL 60173-2213 |
William P Forbes | director | C/O SALIX PHARMACEUTICALS, LTD., 8510 COLONNADE CENTER DRIVE, RALEIGH NC 27615 |
Yoori Lee | director | C/O AIT THERAPEUTICS, INC., 500 MAMARONECK AVENUE, HARRISON NY 10528 |
Ron Bentsur | director | 750 LEXINGTON AVE, 20TH FL, NEW YORK NY 10022 |
Erick Lucera | director | 138 THISTLE ROAD, NORTH ANDOVER MA 08145 |
Douglas Quinton Larson | officer: Chief Financial Officer | BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY NY 11530 |
Douglas Beck | officer: Chief Financial Officer | C/O IBIO, INC., 9 INNOVATION WAY, SUITE 100, NEWARK DE 19711 |
Ari Raved | director | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
Jerome B Zeldis | director | 8767 E. VIA DE VENTURA, SUITE 190, SCOTTSDALE AZ 85258 |
David Grossman | director | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
Haim Aviv | officer: Chief Financial Officer | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
From GuruFocus
By Marketwired • 09-07-2023
By Marketwired • 08-10-2023
By Marketwired • 08-01-2023
By Marketwired • 10-17-2023
By Marketwired • 10-04-2023
By sperokesalga sperokesalga • 06-15-2023
By Stock market mentor Stock market mentor • 01-30-2023
By Marketwired • 10-16-2023
By Marketwired • 10-02-2023
By GuruFocus Research • 12-22-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.